10 Unusual Applications of CRISPR Gene Editing
CRISPR has been all over the news in the past couple of years, and with…
30/03/2020 - 8 minutes
CRISPR: A Promising Industry With Many Questions Unanswered
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
Show More
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportLatest CRISPR Articles
Broad Institute Loses Appeal on European CRISPR Patent
A decision from the Boards of Appeal at the European Patent Office has revoked the…
24/01/2020 - 4 minutes
Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing
Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene…
14/01/2020 - 3 minutes
European Biotech’s Top News in 2019
With the year coming to a close, it’s time to review the most important biotech…
30/12/2019 - 10 minutes
Taking CRISPR Safety to the Next Level
Gene therapies are experiencing a new era. CRISPR is current. CRISPR is trendy. CRISPR is…
11/12/2019 - 7 minutes
CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
19/11/2019 - 3 minutes
Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing
The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company…
09/10/2019 - 1 minute
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
27/09/2019 - 3 minutes
Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once
A research group at ETH Zurich, Switzerland, has made it possible to edit hundreds of…
15/08/2019 - 3 minutes
CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
07/06/2019 - 2 minutes
‘CRISPR Babies’ Might Be at Risk of Dying Younger
Update (01/10/2019): The scientists behind the study have declared that the results were based on…
03/06/2019 - 3 minutes
This Biotech Uses Gene Editing to Count Chickens Before They Hatch
In the city of Jerusalem, eggXYt is developing gene edited chickens whose male chicks fluoresce…
24/05/2019 - 3 minutes
